A review of Gaucher disease pathophysiology, clinical presentation and treatments

J Stirnemann, N Belmatoug, F Camou… - International journal of …, 2017 - mdpi.com
Gaucher disease (GD, ORPHA355) is a rare, autosomal recessive genetic disorder. It is
caused by a deficiency of the lysosomal enzyme, glucocerebrosidase, which leads to an …

Value of glucosylsphingosine (Lyso-Gb1) as a biomarker in Gaucher disease: a systematic literature review

S Revel-Vilk, M Fuller, A Zimran - International journal of molecular …, 2020 - mdpi.com
The challenges in the diagnosis, prognosis, and monitoring of Gaucher disease (GD), an
autosomal recessive inborn error of glycosphingolipid metabolism, can negatively impact …

Glucosylsphingosine promotes α-synuclein pathology in mutant GBA-associated Parkinson's disease

YV Taguchi, J Liu, J Ruan, J Pacheco… - Journal of …, 2017 - Soc Neuroscience
Glucocerebrosidase 1 (GBA) mutations responsible for Gaucher disease (GD) are the most
common genetic risk factor for Parkinson's disease (PD). Although the genetic link between …

Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy

AB Burlina, G Polo, L Salviati, G Duro… - Journal of Inherited …, 2018 - Wiley Online Library
Abstract Background Lysosomal storage diseases (LSDs) are inborn errors of metabolism
resulting from 50 different inherited disorders. The increasing availability of treatments and …

Lysosomal glycosphingolipid storage diseases

B Breiden, K Sandhoff - Annual review of biochemistry, 2019 - annualreviews.org
Glycosphingolipids are cell-type-specific components of the outer leaflet of mammalian
plasma membranes. Gangliosides, sialic acid–containing glycosphingolipids, are especially …

[HTML][HTML] Gaucher disease

GM Pastores, DA Hughes - 2018 - europepmc.org
Gaucher disease (GD) encompasses a continuum of clinical findings from a perinatal lethal
disorder to an asymptomatic type. The identification of three major clinical types (1, 2, and 3) …

Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1

A Dardis, H Michelakakis, P Rozenfeld, K Fumic… - Orphanet journal of rare …, 2022 - Springer
Gaucher disease (GD) is an autosomal recessive lysosomal storage disorder due to the
deficient activity of the acid beta-glucosidase (GCase) enzyme, resulting in the progressive …

The consequences of GBA deficiency in the autophagy–lysosome system in Parkinson's disease associated with GBA

E Pradas, M Martinez-Vicente - Cells, 2023 - mdpi.com
GBA gene variants were the first genetic risk factor for Parkinson's disease. GBA encodes
the lysosomal enzyme glucocerebrosidase (GBA), which is involved in sphingolipid …

Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells, biomarkers, and response to substrate reduction therapy

CS Boddupalli, S Nair, G Belinsky, J Gans, E Teeple… - Elife, 2022 - elifesciences.org
Background: Neuronopathic Gaucher disease (nGD) is a rare neurodegenerative disorder
caused by biallelic mutations in GBA and buildup of glycosphingolipids in lysosomes …

[HTML][HTML] The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?

NJ Weinreb, O Goker-Alpan, PS Kishnani… - Molecular genetics and …, 2022 - Elsevier
Gaucher disease (GD) is an autosomal recessive inherited lysosomal storage disease that
often presents in early childhood and is associated with damage to multiple organ systems …